DCGI Discontinues WHO-GMP Certification

The Drugs Control Society of India (DCGI) has taken a decision to discontinue issuance of WHO-GMP certificate for both pharma products and plant audits. The decision comes in the wake of objection raised by the World Health Organization on handing over these certificates at random.

HCL Technologies To Offer Tech Services To Medical Device Cos

Eying the huge growth potential of Life Sciences and Healthcare Sectors and the resultant growing need for advanced medical devices, India’s leading IT service provider HCL Technologies Ltd. will offer advanced technology services to the medical devices companies for exploring the emerging markets with low cost products.

Commerce Ministry Extends DEPB Scheme Withdraws Reduction In DEPB Rates

Owing to the tremendous pressure exerted by the exporting community in the country, the Union commerce ministry has extended the DEPB (duty entitled passbook) scheme till December 31, 2009. Moreover, the ministry has withdrawn, with retrospective effect, its last year’s decision to reduce the DEPB rates by 2 per cent.

Nirmed Invests Rs 3 Cr For Greenfield Project To Manufacture Wound Care Products

Nirmed Healthcare has invested Rs 3 crore to set up a facility in Bangalore to manufacture a range of wound dressing products. The company is a special purpose vehicle of the decade-old Siddhi Vinayaka Spechem Private Limited which is engaged in exporting quality biochemical reagent and intermediates to the regulated markets of US and Europe.

DuPont Opens Integrated Knowledge Center In India

DuPont India, a subsidiary of US-based science-based products and services company DuPont, has opened its integrated knowledge centre - DuPont Knowledge Centre (DKC) - at Hyderabad to provide basic discovery research and applications development services.

Marck To Set Up Sterile Dosages Facility With Rs 800 Mn

The Ahmedabad-based Marck Biosciences Ltd, a leading manufacturer and marketer of sterile dosages pharma products, is all set to set up a new facility to consolidate its position in the growing sterile dosages pharma market. The company would make an investment of Rs 800 million over the next three years for this end.

GE Healthcare To Invest $50-60 Mn In India In 3 Years

GE Healthcare is planning an investment of $50-$60 million in India over the next three years as part of the public-private partnership efforts in the country. The company will tap the outsourcing opportunities to offer its radiology technology at the healthcare facilities in 10 states.